Chemokine contribution in stem cell engraftment into the infarcted myocardium
Elisa A Liehn1, Eugen Radu, Alexander Schuh
1Institute for Molecular Cardiovascular Research, RWTH Aachen University, Germany. eliehn@ukaachen.de
Insights
Cardiovascular disease remains a global health crisis. This review explores how chemokines can improve cell therapy for heart attack repair, enhancing stem cell effectiveness in damaged heart tissue.
Area of Science:
- Cardiology
- Regenerative Medicine
- Immunology
Background:
- Cardiovascular diseases, particularly myocardial infarction (MI), are leading causes of death globally.
- Current treatments for MI improve prognosis but do not fully restore cardiac function or repair damaged tissue.
- Cell-based therapy shows promise for cardiac repair but has faced challenges in clinical efficacy.
Purpose of the Study:
- To review current knowledge on cell-based therapy for myocardial infarction.
- To highlight the role of chemokines in enhancing stem cell engraftment in infarcted myocardium.
- To discuss the potential clinical implications of chemokine-mediated strategies in cardiac regenerative medicine.
Main Methods:
- Literature review of studies on cell therapy and chemokines in myocardial infarction.
- Analysis of mechanisms underlying stem cell behavior in the infarcted heart.
- Synthesis of findings on the impact of chemokines on cell engraftment and therapeutic outcomes.
Main Results:
- Cell therapy efficacy in MI has been limited by poor cell survival and integration.
- Chemokines play a crucial role in attracting and retaining stem cells within the infarcted myocardium.
- Targeting chemokine pathways can significantly improve stem cell engraftment and cardiac repair.
Conclusions:
- Optimizing cell therapy for MI requires strategies to enhance stem cell homing and survival.
- Chemokines represent a promising therapeutic target to improve the efficacy of cell-based regenerative approaches for heart disease.
- Further research into chemokine-stem cell interactions is warranted for clinical translation in cardiovascular medicine.
Abstract:
Modern life styles have made cardiovascular disease the leading cause of morbidity and mortality worldwide. Although current treatments substantially ameliorate patients' prognosis after MI, they cannot restore the affected tissue or entirely re-establish organ function. Therefore, the main goal of modern cardiology should be to design strategies to reduce myocardial necrosis and optimize cardiac repair following MI. Cell-based therapy was considered a novel and potentially new strategy in regenerative medicine; however, its clinical implementation has not yielded the expected results. Chemokines seem to increase the efficiency of cell-therapy and may represent a reliable method to be exploited in the future. This review surveys current knowledge of cell therapy and highlights key insights into the role of chemokines in stem cell engraftment in infarcted myocardium and their possible clinical implications.
More Related Videos
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
01:21Myocarditis I: Introduction